Annual CFF
$414.00 K
-$30.92 M-98.68%
31 December 2023
Summary:
Clearside Biomedical annual cash flow from financing activities is currently $414.00 thousand, with the most recent change of -$30.92 million (-98.68%) on 31 December 2023. During the last 3 years, it has fallen by -$7.45 million (-94.74%). CLSD annual CFF is now -99.52% below its all-time high of $86.39 million, reached on 31 December 2016.CLSD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$14.00 K
+$14.00 K+100.00%
30 September 2024
Summary:
Clearside Biomedical quarterly cash flow from financing activities is currently $14.00 thousand, with the most recent change of +$14.00 thousand (+100.00%) on 30 September 2024. Over the past year, it has dropped by -$303.00 thousand (-95.58%). CLSD quarterly CFF is now -99.98% below its all-time high of $79.02 million, reached on 31 March 2018.CLSD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$14.10 M
-$303.00 K-2.10%
30 September 2024
Summary:
Clearside Biomedical TTM cash flow from financing activities is currently $14.10 million, with the most recent change of -$303.00 thousand (-2.10%) on 30 September 2024. Over the past year, it has increased by +$12.85 million (+1031.62%). CLSD TTM CFF is now -84.59% below its all-time high of $91.52 million, reached on 31 March 2017.CLSD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLSD Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -98.7% | -95.6% | +1031.6% |
3 y3 years | -94.7% | -99.3% | -53.8% |
5 y5 years | -99.5% | -99.4% | +36.1% |
CLSD Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -98.7% | at low | -100.0% | +105.5% | -55.4% | +3305.8% |
5 y | 5 years | -99.5% | at low | -100.0% | +100.5% | -55.4% | +2213.9% |
alltime | all time | -99.5% | at low | -100.0% | +100.5% | -84.6% | +2213.9% |
Clearside Biomedical Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $14.00 K(>+9900.0%) | $14.10 M(-2.1%) |
June 2024 | - | $0.00(-100.0%) | $14.40 M(-0.2%) |
Mar 2024 | - | $14.34 M(-5680.9%) | $14.43 M(+3384.3%) |
Dec 2023 | $414.00 K(-98.7%) | -$257.00 K(-181.1%) | $414.00 K(-66.8%) |
Sept 2023 | - | $317.00 K(+1340.9%) | $1.25 M(-96.1%) |
June 2023 | - | $22.00 K(-93.4%) | $31.62 M(+0.1%) |
Mar 2023 | - | $332.00 K(-42.3%) | $31.60 M(+0.9%) |
Dec 2022 | $31.33 M(+31.8%) | $575.00 K(-98.1%) | $31.33 M(+1.3%) |
Sept 2022 | - | $30.69 M(>+9900.0%) | $30.92 M(+1235.8%) |
June 2022 | - | $4000.00(-93.8%) | $2.31 M(-75.4%) |
Mar 2022 | - | $65.00 K(-60.6%) | $9.43 M(-60.4%) |
Dec 2021 | $23.78 M(+202.3%) | $165.00 K(-92.1%) | $23.78 M(-22.0%) |
Sept 2021 | - | $2.08 M(-70.8%) | $30.50 M(-1.1%) |
June 2021 | - | $7.12 M(-50.6%) | $30.85 M(+46.3%) |
Mar 2021 | - | $14.42 M(+109.5%) | $21.09 M(+168.1%) |
Dec 2020 | $7.87 M(-9.5%) | $6.88 M(+183.4%) | $7.87 M(-1288.4%) |
Sept 2020 | - | $2.43 M(-192.0%) | -$662.00 K(-0.7%) |
June 2020 | - | -$2.64 M(-321.2%) | -$667.00 K(-120.5%) |
Mar 2020 | - | $1.19 M(-172.5%) | $3.26 M(-62.5%) |
Dec 2019 | $8.70 M | -$1.65 M(-167.9%) | $8.70 M(-16.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2019 | - | $2.42 M(+88.2%) | $10.36 M(+30.5%) |
June 2019 | - | $1.29 M(-80.6%) | $7.94 M(-15.5%) |
Mar 2019 | - | $6.63 M(>+9900.0%) | $9.39 M(-88.5%) |
Dec 2018 | $81.78 M(+1425.2%) | $20.00 K(>+9900.0%) | $81.78 M(-0.1%) |
Sept 2018 | - | $0.00(-100.0%) | $81.83 M(-0.0%) |
June 2018 | - | $2.74 M(-96.5%) | $81.83 M(+3.3%) |
Mar 2018 | - | $79.02 M(>+9900.0%) | $79.25 M(+1377.9%) |
Dec 2017 | $5.36 M(-93.8%) | $69.00 K(+6800.0%) | $5.36 M(-86.2%) |
Sept 2017 | - | $1000.00(-99.4%) | $38.77 M(-17.2%) |
June 2017 | - | $159.00 K(-96.9%) | $46.81 M(-48.9%) |
Mar 2017 | - | $5.13 M(-84.7%) | $91.52 M(+5.9%) |
Dec 2016 | $86.39 M(+233.0%) | $33.48 M(+316.4%) | $86.39 M(+18.6%) |
Sept 2016 | - | $8.04 M(-82.1%) | $72.86 M(+12.4%) |
June 2016 | - | $44.88 M(>+9900.0%) | $64.83 M(+149.9%) |
Mar 2016 | - | $0.00(-100.0%) | $25.94 M(0.0%) |
Dec 2015 | $25.94 M(+66.1%) | $19.95 M(>+9900.0%) | $25.94 M(+332.8%) |
Sept 2015 | - | $6000.00(-99.9%) | $5.99 M(+0.1%) |
June 2015 | - | $5.99 M(>+9900.0%) | $5.99 M(>+9900.0%) |
Mar 2015 | - | $0.00 | $0.00 |
Dec 2014 | $15.62 M(+96.4%) | - | - |
Dec 2013 | $7.96 M | - | - |
FAQ
- What is Clearside Biomedical annual cash flow from financing activities?
- What is the all time high annual CFF for Clearside Biomedical?
- What is Clearside Biomedical annual CFF year-on-year change?
- What is Clearside Biomedical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Clearside Biomedical?
- What is Clearside Biomedical quarterly CFF year-on-year change?
- What is Clearside Biomedical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Clearside Biomedical?
- What is Clearside Biomedical TTM CFF year-on-year change?
What is Clearside Biomedical annual cash flow from financing activities?
The current annual CFF of CLSD is $414.00 K
What is the all time high annual CFF for Clearside Biomedical?
Clearside Biomedical all-time high annual cash flow from financing activities is $86.39 M
What is Clearside Biomedical annual CFF year-on-year change?
Over the past year, CLSD annual cash flow from financing activities has changed by -$30.92 M (-98.68%)
What is Clearside Biomedical quarterly cash flow from financing activities?
The current quarterly CFF of CLSD is $14.00 K
What is the all time high quarterly CFF for Clearside Biomedical?
Clearside Biomedical all-time high quarterly cash flow from financing activities is $79.02 M
What is Clearside Biomedical quarterly CFF year-on-year change?
Over the past year, CLSD quarterly cash flow from financing activities has changed by -$303.00 K (-95.58%)
What is Clearside Biomedical TTM cash flow from financing activities?
The current TTM CFF of CLSD is $14.10 M
What is the all time high TTM CFF for Clearside Biomedical?
Clearside Biomedical all-time high TTM cash flow from financing activities is $91.52 M
What is Clearside Biomedical TTM CFF year-on-year change?
Over the past year, CLSD TTM cash flow from financing activities has changed by +$12.85 M (+1031.62%)